Bharat Biotech to submit Covid nasal vaccine trial data to DCGI next month Ruchika Sharma20 Jun 2022 12:00 PM ISTIndia's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its Covid-19 nasal...
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years, says Bharat Biotech Ruchika Sharma17 Jun 2022 12:46 PM ISTCOVAXIN is a ready to use liquid vaccine, stored at 2-8°C, with 12 months shelf life and multi dose vial policy.
Bharat Biotech Covaxin booster dose broadens immunity against Delta, Omicron variants: ICMR study Ruchika Sharma15 Jun 2022 4:15 PM ISTNew Delhi: The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection...
Bharat Biotech Covaxin to be recognized in Germany for travel from June 1 Ruchika Sharma28 May 2022 9:30 AM ISTCovaxin is a ready-to-use liquid vaccine, stored at 2-8 degrees Celsius, with 12 months shelf life and a multi-dose vial policy.
USFDA removes clinical hold on Covaxin trial: Ocugen Ruchika Sharma24 May 2022 12:33 PM ISTCOVAXIN is listed by the World Health Organization (WHO) as authorized for emergency use.
Serum Institute seeks CDSCO permission for Phase-3 trial of Covovax as booster dose in children aged 2-18 Ruchika Sharma24 May 2022 12:03 PM ISTThe study will evaluate the immunogenicity and safety of the vaccine as a booster dose in comparison with the placebo.
Bharat Biotech, CEPI collaborate to develop 'variant-proof' COVID vaccine Ruchika Sharma11 May 2022 12:24 PM ISTCEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
Bharat Biotech must address WHO's Covaxin suspension to avoid emergency use approval cancellation: MEA Ruchika Sharma29 April 2022 10:00 AM ISTThe communication stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of...
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children Dr. Nandita Mohan27 April 2022 5:43 PM ISTThe Drugs Controller General of India (DCGI) on Tuesday approved three Covid vaccines for the restricted emergency use authorisation (EUA) for...
Andhra Pradesh: VIMS to conduct intranasal COVID vaccine trials Adity Saha27 April 2022 1:02 PM ISTVisakhapatnam: Visakha Institute of Medical Science (VIMS) is one of the ten volunteers and the only institution in Andhra Pradesh to start human...
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of children MD Bureau26 April 2022 5:00 PM ISTDCGI approved restricted use for emergency situation to ZycovD for children above the age of 12 years for a two-dose regimen.
